Brief: Celltrion Signs 25.2 Bln Won Deal
May 14 (Reuters) - Celltrion Inc 068270.KS says:
* SIGNS 25.2 BILLION WON DEAL
* SIGNS DEAL WITH CELLTRION HEALTHCARE TO SELL TRUXIMA
Source text for Eikon: [ID:https://bit.ly/30h3mD9]
Further company coverage: 068270.KS
((hyunjoo.jin@thomsonreuters.com;))
Recent news on Celltrion Healthcare Co
See all newsBrief: Celltrion USA says Ventegra Will Place FDA-Approved Biosimilar To Avastin , Vegzelma On Its Commercial Formulary As A Preferred Brand
Brief: Celltrion Healthcare To Acquire 92.7 Billion Won Worth Of Own Shares
Brief: Celltrion Healthcare Q3 Operating Profit 50.5 Billion Won, Down 30.4% From Year Earlier
Brief: Celltrion Usa- Announces Distribution And Incorporation Of Yuflyma (Adalimumab-Aaty) To Carepartners Specialty Pharmacy Cost Savings Programs
Brief: Celltrion Healthcare's Merger With Celltrion Approved In Shareholder Meeting -Yonhap